(NASDAQ: DTIL) Precision Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.2%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.27%.
Precision Biosciences's earnings in 2026 is -$43,600,000.On average, 6 Wall Street analysts forecast DTIL's earnings for 2026 to be -$75,007,132, with the lowest DTIL earnings forecast at -$111,259,289, and the highest DTIL earnings forecast at -$31,698,060. On average, 6 Wall Street analysts forecast DTIL's earnings for 2027 to be -$70,731,700, with the lowest DTIL earnings forecast at -$96,087,568, and the highest DTIL earnings forecast at -$38,742,074.
In 2028, DTIL is forecast to generate -$70,992,302 in earnings, with the lowest earnings forecast at -$83,444,467 and the highest earnings forecast at -$53,101,024.